Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Forte Biosciences (FBRX) Interest & Investment Income (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Interest & Investment Income for 5 consecutive years, with $58000.0 as the latest value for Q1 2020.

  • On a quarterly basis, Interest & Investment Income fell 89.28% to $58000.0 in Q1 2020 year-over-year; TTM through Mar 2020 was $1.1 million, a 38.58% decrease, with the full-year FY2019 number at $1.6 million, up 1.96% from a year prior.
  • Interest & Investment Income was $58000.0 for Q1 2020 at Forte Biosciences, down from $197000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $541000.0 in Q1 2019 to a low of $37000.0 in Q1 2017.
  • A 5-year average of $256600.0 and a median of $241000.0 in 2017 define the central range for Interest & Investment Income.
  • Peak YoY movement for Interest & Investment Income: surged 751.35% in 2018, then crashed 89.28% in 2020.
  • Forte Biosciences' Interest & Investment Income stood at $45000.0 in 2016, then skyrocketed by 435.56% to $241000.0 in 2017, then skyrocketed by 85.48% to $447000.0 in 2018, then tumbled by 55.93% to $197000.0 in 2019, then tumbled by 70.56% to $58000.0 in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Interest & Investment Income are $58000.0 (Q1 2020), $197000.0 (Q4 2019), and $361000.0 (Q3 2019).